Efficacy and safety of topical cyclosporine A 0.05% in vernal keratoconjunctivitis

Creative Commons License

Yucel Ö., Ulus N. D.

SINGAPORE MEDICAL JOURNAL, cilt.57, sa.9, ss.507-510, 2016 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 57 Sayı: 9
  • Basım Tarihi: 2016
  • Doi Numarası: 10.11622/smedj.2015161
  • Dergi Adı: SINGAPORE MEDICAL JOURNAL
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.507-510
  • Anahtar Kelimeler: allergic conjunctivitis, cyclosporine A, restasis, vernal keratoconjunctivitis, ALLERGIC CONJUNCTIVITIS, CHILDREN, EYEDROPS, TRIAL
  • Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
  • Ondokuz Mayıs Üniversitesi Adresli: Evet

Özet

INTRODUCTION While corticosteroids are an effective choice of treatment for severe vernal keratoconjunctivitis (VKC), their long-term use is restricted due to side effects. This study was conducted to evaluate the efficacy and safety of topical cyclosporine A (CsA) 0.05% in the treatment of VKC.